Pioglitazone, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, GLIMEPIRIDE, GLICLAZIDE, METFORMIN HYDROCHLORIDE, GLIPIZIDE, METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN, GLIQUIDONE, Placebo for Actos 15 mg tablets, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE
CT-L03-301
Phase 3 small_molecule active
Quick answer
Pioglitazone, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, GLIMEPIRIDE, GLICLAZIDE, METFORMIN HYDROCHLORIDE, GLIPIZIDE, METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN, GLIQUIDONE, Placebo for Actos 15 mg tablets, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE for Type 2 diabetes mellitus (T2DM) is a Phase 3 program (small_molecule) at Celltrion Healthcare Hungary Kft. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celltrion Healthcare Hungary Kft.
- Indication
- Type 2 diabetes mellitus (T2DM)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active